869335-22-8

Basic information

• Product Name: 1H-Pyrrolo[2,3-b]pyridine, 6-chloro-4-nitro-1-[[2-(triMethylsilyl)ethoxy]Methyl]-
• Synonyms: 1H-Pyrrolo[2,3-b]pyridine, 6-chloro-4-nitro-1-[[2-(triMethylsilyl)ethoxy]Methyl]-3;1H-Pyrrolo[2,3-b]pyridine, 6-chloro-4-nitro-1-[[2-(triMethylsilyl)ethoxy]Methyl]-;6-Chloro-4-nitro-1-((2-(trimethylsilyl)ethoxy)-methyl)-1H-pyrrolo[2,3-b]pyridine
• CAS NO: 869335-22-8
• Molecular Formula: C₁₃H₁₈ClN₃O₃Si
• Molecular Weight: 327.842
• Mol File: 869335-22-8.mol

Chemical Properties

• Boiling Point: 420.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.26±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -2.14±0.30(Predicted)
• CAS DataBase Reference: 1H-Pyrrolo[2,3-b]pyridine, 6-chloro-4-nitro-1-[[2-(triMethylsilyl)ethoxy]Methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrolo[2,3-b]pyridine, 6-chloro-4-nitro-1-[[2-(triMethylsilyl)ethoxy]Methyl]-(869335-22-8)
• EPA Substance Registry System: 1H-Pyrrolo[2,3-b]pyridine, 6-chloro-4-nitro-1-[[2-(triMethylsilyl)ethoxy]Methyl]-(869335-22-8)

Safety Data

• Hazardous Substances Data: 869335-22-8(Hazardous Substances Data)

Usage

Uses

Used in Medicinal Chemistry:
1H-Pyrrolo[2,3-b]pyridine, 6-chloro-4-nitro-1-[[2-(triMethylsilyl)ethoxy]Methyl]is used as a chemical compound in medicinal chemistry for its unique structural features. Its pyrrolopyridine core, chloro-nitro substitution, and ethoxymethyl and trimethylsilyl groups may offer potential applications in drug discovery and development. Further research is required to explore its properties and potential uses in this field.

Upstream product

• 688781-87-5 6-chloro-4-nitro-1H-pyrrolo[2,3-b]pyridine 
• 76513-69-4 (2-trimethylethylsilylethoxy)methyl chloride 
• 74420-06-7 4-nitro-1H-pyrrolo<2,3-b>pyridine 7-oxide 

Downstream Products

• 881902-81-4 4-[6-chloro-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrrolo[2,3-b]pyridin-4-yloxy]-3-fluoro-phenylamine 
• 869335-30-8 (6-chloro-1-([2-(trimethylsilyl)ethoxy]methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)(2-fluoro-4-nitrophenyl)acetic acid methyl ester 
• 1115491-38-7 C₁₉H₂₂ClF₂N₃O₂Si 
• 1315355-93-1 3-((1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide 
• 1415564-64-5 C₂₁H₂₅ClN₂O₄Si 
• 881902-82-5 3-fluoro-4-[1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrrolo[2,3-b]pyridin-4-yloxy]-phenylamine 
• 688781-75-1 3-fluoro-4-((1H-pyrrolo [2,3-b]pyridin-4-yl)oxy)aniline 

Relevant articles and documents

AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS

The invention relates to compounds of formula I inhibiting Rho Kinase that are tyrosine analogues derivatives, processes of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. Particularly the compounds of the invention may be useful in the treatment of many disorders associated with ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).

AZAINDOLE DERIVATIVES AS RHO- KINASE INHIBITORS

The invention relates to compounds of formula (I) inhibiting Rho Kinase that are azaindole derivatives, methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof Particularly the compounds of the inventio

TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS

Bicyclic dihydropyrimidine-carboxamide compounds of formula I described herein inhibit Rho Kinase and may be used for the treatment of many disorders associated with ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).

Improved synthesis of the selective rho-kinase inhibitor 6-chloro-n4-{3,5-difluoro-4-[(3-methyl-1h-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl} pyrimidin-2,4-diamine

A highly potent and selective Rho-kinase inhibitor containing a 7-azaindole moiety has been developed at Bayer Schering Pharma. Herein we disclose details of a significantly improved synthesis of the compound in 8.2% overall yield. Key aspects include cost and safety considerations and the uncommon use of a trifluoromethyl group with controllable reactivity as a masked methyl group.

Substituted Phenylamino-Pyrimidines

The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.

Efficient synthesis of 4-O- and C-substituted-7-azaindoles

6-Chloro-4-nitro- and 4,6-dichloro-1H-pyrrolo[2,3-b]pyridine are versatile building blocks that allow the synthesis of 4-substituted 7-azaindole derivatives by simple nucleophilic displacement of the 4-substituent. Herein, we report on their reaction with

SUBSTITUTED PHENYLAMINO-PYRIMIDINES

The invention relates to substituted phenylamino-pyrimidines, to a method for their production and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular for the treatment of cardiovascular diseases.